Skip to main content

and
  1. Article

    Open Access

    MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors

    Our previous study has shown that PTPRZ1-MET (ZM) fusion is a viable target for MET inhibitors in gliomas. However, the diversity and prevalence of somatic MET alterations in diffuse gliomas are still elusive and...

    Ke-Nan Zhang, Zheng Zhao, **g Chen, Zhaoshi Bao in Holistic Integrative Oncology (2022)